Navigation Links
ChemAxon and Agilent Technologies Sign Agreement Extending JChem Integration With Kalabie Electronic Lab Notebook
Date:9/21/2007

BUDAPEST, Hungary and SANTA CLARA, California, September 21 /PRNewswire/ -- ChemAxon, a software solutions provider for cheminformatics, and Agilent Technologies Inc. (NYSE: A) today announced an agreement to maintain the integration between the Kalabie Electronic Laboratory Notebook (ELN) and ChemAxon's software suite. Agilent acquired the Kalabie ELN from Klee in June 2007. The contract transitions existing agreements between Klee and ChemAxon to Agilent and ChemAxon.

"We are very pleased to be working with Agilent, as our cheminformatics toolkits are particularly relevant to their current and future strategy," said Ferenc Csizmadia, CEO of ChemAxon.

"Kalabie's unique open design allows easy and effective integration to chemistry cartridge technologies," said Alain Meller, Agilent's ELN director. "The integration with ChemAxon's JChem offers an integrated solution that is seamless in software and services."

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 19,000 employees serve customers in more than 110 countries. Agilent had net revenue of $5.0 billion in fiscal year 2006. Information about Agilent is available on the Web at http://www.agilent.com.

About ChemAxon

ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit http://www.chemaxon.com.

Note to Editors: Further technology, corporate citizenship and executive news is available on the Agilent news site at http://www.agilent.com/go/news.


'/>"/>
SOURCE ChemAxon Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Monitoring transfection efficiency by green fluorescent protein (GFP) detection with the Agilent 2100 bioanalyzer
2. Apoptosis detection by annexin V and active caspase-3 with the Agilent 2100 bioanalyzer
3. Measuring multiple apoptosis parameters with the Agilent 2100 bioanalyzer
4. Flow cytometric analysis of human primary cells using the Agilent 2100 bioanalyzer and on-chip staining
5. Agilent 2100 Bioanalyzer Automated Analysis System
6. Detection of antibody-stained cell surface and intracellular protein targets with the Agilent 2100 bioanalyzer
7. 2100 expert software Powerful software for the analysis of RNA, DNA, proteins, and cells with the Agilent 2100 bioanalyzer
8. siRNA transfection optimization with the Agilent 2100 bioanalyzer
9. Quantitative end-point RT-PCR gene expression measurement using the Agilent 2100 Bioanalyzer and standardized RT-PCR
10. Using the Agilent 2100 bioanalyzer for quality control of protein samples prior to MS-analysis
11. Rapid detection of genomic duplications and deletions using the Agilent 2100 bioanalyzer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are ... 5.5 million people each year. Especially those living in larger cities are affected by ... in one of the most pollution-affected countries globally - decided to take action. , ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
Breaking Biology Technology:
(Date:4/24/2017)... , April 24, 2017 ... and partner with  Identity Strategy Partners, LLP (IdSP) ... "With or without President Trump,s March 6, 2017 ... Terrorist Entry , refugee vetting can be instilled with ... resettlement. (Right now, all refugee applications are suspended ...
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
Breaking Biology News(10 mins):